Peters K
Immunol Rev. 2022; 313(1):217-224.
PMID: 36408746
PMC: 10099761.
DOI: 10.1111/imr.13165.
Zhang S, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova J
Curr Opin Immunol. 2019; 59:88-100.
PMID: 31121434
PMC: 6774828.
DOI: 10.1016/j.coi.2019.03.008.
Turley A, Gathmann B, Bangs C, Bradbury M, Seneviratne S, Gonzalez-Granado L
J Clin Immunol. 2015; 35(2):199-205.
PMID: 25663093
DOI: 10.1007/s10875-015-0137-5.
Achila D, Liu A, Banerjee R, Li Y, Martinez-Hackert E, Zhang J
Biochem J. 2014; 465(2):325-35.
PMID: 25330773
PMC: 5600146.
DOI: 10.1042/BJ20141069.
Barbour T, Pickering M, Cook H
Semin Nephrol. 2013; 33(6):493-507.
PMID: 24161036
PMC: 3820036.
DOI: 10.1016/j.semnephrol.2013.08.002.
The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.
Ren B, Li J, Genschmer K, Hollingshead S, Briles D
Clin Vaccine Immunol. 2012; 19(10):1574-82.
PMID: 22855389
PMC: 3485889.
DOI: 10.1128/CVI.00393-12.
Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.
Ram S, Lewis L, Agarwal S
J Biol Chem. 2011; 286(10):8297-8307.
PMID: 21245150
PMC: 3048715.
DOI: 10.1074/jbc.M110.184838.
Species-specific interaction of Streptococcus pneumoniae with human complement factor H.
Lu L, Ma Z, Jokiranta T, Whitney A, DeLeo F, Zhang J
J Immunol. 2008; 181(10):7138-46.
PMID: 18981135
PMC: 2587499.
DOI: 10.4049/jimmunol.181.10.7138.
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
Chan M, Thomas C, Torrealba J, Djamali A, Fernandez L, Nishimura C
Am J Kidney Dis. 2008; 53(2):321-6.
PMID: 18805611
PMC: 2879708.
DOI: 10.1053/j.ajkd.2008.06.027.
Pathogenesis of thrombotic microangiopathies.
Zheng X, Sadler J
Annu Rev Pathol. 2008; 3:249-77.
PMID: 18215115
PMC: 2582586.
DOI: 10.1146/annurev.pathmechdis.3.121806.154311.
Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family.
Grumach A, Leitao M, Arruk V, Kirschfink M, Condino-Neto A
Clin Exp Immunol. 2006; 143(2):297-304.
PMID: 16412054
PMC: 1809586.
DOI: 10.1111/j.1365-2249.2005.02988.x.
Antiinflammatory and immunomodulating properties of fungal metabolites.
Lull C, Wichers H, Savelkoul H
Mediators Inflamm. 2005; 2005(2):63-80.
PMID: 16030389
PMC: 1160565.
DOI: 10.1155/MI.2005.63.
Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Kerr A, Paterson G, Riboldi-Tunnicliffe A, Mitchell T
Infect Immun. 2005; 73(7):4245-52.
PMID: 15972516
PMC: 1168602.
DOI: 10.1128/IAI.73.7.4245-4252.2005.
Exceptional matters.
Peters K
Lancet. 2004; 364(9451):2142-51.
PMID: 15589313
PMC: 7137743.
DOI: 10.1016/S0140-6736(04)17556-9.
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
Brown J, Hussell T, Gilliland S, Holden D, Paton J, Ehrenstein M
Proc Natl Acad Sci U S A. 2002; 99(26):16969-74.
PMID: 12477926
PMC: 139253.
DOI: 10.1073/pnas.012669199.
Complement deficiency.
ONeil K
Clin Rev Allergy Immunol. 2000; 19(2):83-108.
PMID: 11107496
DOI: 10.1385/CRIAI:19:2:83.
Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
Sikkema D, Friedman K, Corsaro B, Kimura A, Hildreth S, Madore D
Clin Diagn Lab Immunol. 2000; 7(5):764-8.
PMID: 10973451
PMC: 95952.
DOI: 10.1128/CDLI.7.5.764-768.2000.
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection.
Boes M, Prodeus A, Schmidt T, Carroll M, Chen J
J Exp Med. 1998; 188(12):2381-6.
PMID: 9858525
PMC: 2212438.
DOI: 10.1084/jem.188.12.2381.
Abrogation of the alternative complement pathway by targeted deletion of murine factor B.
Matsumoto M, Fukuda W, Circolo A, Goellner J, Strauss-Schoenberger J, Wang X
Proc Natl Acad Sci U S A. 1997; 94(16):8720-5.
PMID: 9238044
PMC: 23097.
DOI: 10.1073/pnas.94.16.8720.
Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
Williams A, Hastings M, Easmon C, COLE P
Immunology. 1980; 41(4):903-11.
PMID: 7007217
PMC: 1458310.
